Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study
2020 ◽
pp. annrheumdis-2020-218243
◽
Keyword(s):
2020 ◽
pp. annrheumdis-2020-218693
Keyword(s):
2020 ◽
pp. annrheumdis-2020-218836
◽
Keyword(s):
2011 ◽
Vol 285
(1)
◽
pp. 143-148
◽
Keyword(s):
2011 ◽
Vol 125
(2)
◽
pp. 111-115
◽
2016 ◽
Vol 38
(1)
◽
pp. 69-74
◽
Keyword(s):
Keyword(s):
Keyword(s):